Evidence map›Paper›PMID 38831872›Full record

ReviewOrthopaedic journal of sports medicine2024

Mid- to Long-Term Outcomes in Patients After Hip Arthroscopy With Labral Reconstruction: A Systematic Review.

David Nam-Woo Kim, Scott Fong, Nancy Park, Jacquelyn Simington, Louise Atadja, Nicholas Pettinelli, Michael S Lee, Stephen M Gillinov, David R Maldonado, Andrew E Jimenez

Registry-linked trialAbstract readReview
In one paragraph

Review in Orthopaedic journal of sports medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06750757 (Intraoperative Bone Marrow Aspirate Concentrate Injections), which is not on this map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06750757 phase4not yet recruitingnot on this mapstarted 2025, after this paper: background citation

Intraoperative Bone Marrow Aspirate Concentrate Injections: Evaluating Outcomes in a Randomized Controlled Trial

TypeinterventionalSponsorAmerican Hip InstituteRan2025 to 2028Enrolled80ConditionsLabral Tear, Femoroacetabular ImpingementArmsBone marrow aspirate concentrate, Hip arthroscopy
3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

David Nam-Woo KimDepartment of Orthopaedics and Rehabilitation, Yale School of Medicine, New Haven, Connecticut, USA.
Scott FongCase Western Reserve University School of Medicine, Cleveland, Ohio, USA.
Nancy ParkDepartment of Orthopaedics and Rehabilitation, Yale School of Medicine, New Haven, Connecticut, USA.
Jacquelyn SimingtonDepartment of Orthopaedics and Rehabilitation, Yale School of Medicine, New Haven, Connecticut, USA.
Louise AtadjaDepartment of Orthopaedics and Rehabilitation, Yale School of Medicine, New Haven, Connecticut, USA.
Nicholas PettinelliKansas City University College of Osteopathic, Kansas City, Missouri, USA.
Michael S LeeMedical College of Wisconsin, Milwaukee, Wisconsin, USA.
Stephen M GillinovDepartment of Orthopaedics and Rehabilitation, Yale School of Medicine, New Haven, Connecticut, USA.
David R MaldonadoDepartment of Orthopedic Surgery, McGovern Medical School, Houston, Texas, USA.
Andrew E JimenezDepartment of Orthopaedics and Rehabilitation, Yale School of Medicine, New Haven, Connecticut, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: There is a paucity of aggregate data documenting mid- to long-term outcomes of patients after hip arthroscopy with labral reconstruction. Purpose: To report mid- to long-term outcomes in patients after undergoing either primary or revision hip arthroscopy with labral reconstruction for the treatment of irreparable labral tears. Study Design: Systematic review; Level of evidence, 4. Methods: A systematic review of the PubMed, Cochrane, and Scopus databases in May 2022 was conducted with the following keywords: "hip arthroscopy,""labral reconstruction,""irreparable,""labrum,""reconstruction,""five-year,""midterm,""5 year,""long-term,""10 year," ten-year," and "femoroacetabular impingement" using the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses criteria. Midterm was defined as mean 5-year follow-up, and long-term was defined as mean 10-year or longer follow-up. For each included article, the demographic, radiographic, intraoperative, and surgical variables, as well as patient-reported outcomes (PROs), psychometric thresholds, and secondary surgeries were recorded. Forest plots were created for PROs that were reported in ≥3 studies; heterogeneity was assessed using Results: Out of 463 initial articles, 5 studies including 178 hips with primary and 41 hips with revision surgeries were included. One study had an average 5-year follow-up, three studies had a minimum 5-year follow-up and one study had a minimum 10-year follow-up. The most common indications for hip arthroscopy with labral reconstruction were irreparable labral tears. The most common PRO was the modified Harris Hip Score (mHHS), which was reported in all 5 studies. The mean preoperative mHHS ranged from 58.9 to 66, and the mean postoperative mHHS at minimum 5-year follow-up ranged from 80.2 to 89. The preoperative and postoperative mHHSs for the single long-term follow-up study were 60 and 82, respectively. All 5 studies demonstrated significant improvements in reported PROs. All 5 studies reported secondary surgery rates, with 1 study reporting rates at both 5- and 10-year follow-up. Conversion to total hip arthroplasty ranged from 0% to 27%, while overall secondary surgery rates ranged from 0% to 36%. Conclusion: Findings demonstrated that patients undergoing primary and revision hip arthroscopy with labral reconstruction experienced favorable outcomes and high rates of clinical benefit and survivorship at mid- to long-term follow-up.

Indexed as

hip arthroscopylabral reconstructionoutcomes

Identifiers

PMID38831872
PMCPMC11144364

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.